IOL Chemicals and Pharmaceuticals Limited

35%

017 Largest producer of Ibuprofen and the only company worldwide being backward integrated with ~35% Global share Spread over a sprawling campus of over 150 acres Key Highlights Largest producer

30%

a Zero Discharge Effluent Treatment Plant 2nd Largest producer of Iso Butyl Benzene (IBB) with ~30% Global share Customer base across 80 countries Over 20 products are commercialized with 8 produc

17.5%

filed and 3 CEP approved during the year 2022-23 587.2 Revenues (Rs. cr) 104.5 EBITDA (Rs. cr) 17.5% EBITDA Margin 65.3 Profit After Tax (Rs. cr) 11.0% PAT Margin FY23 Financial Performance 221

11.0%

2 Revenues (Rs. cr) 104.5 EBITDA (Rs. cr) 17.5% EBITDA Margin 65.3 Profit After Tax (Rs. cr) 11.0% PAT Margin FY23 Financial Performance 2217.1 Revenues (Rs. cr) 252.1 EBITDA (Rs. cr) 11.2% EB

11.2%

11.0% PAT Margin FY23 Financial Performance 2217.1 Revenues (Rs. cr) 252.1 EBITDA (Rs. cr) 11.2% EBITDA Margin 140.0 Profit After Tax (Rs. cr) 6.2% PAT Margin 5 300 250 200 150 2000 16

6.2%

Revenues (Rs. cr) 252.1 EBITDA (Rs. cr) 11.2% EBITDA Margin 140.0 Profit After Tax (Rs. cr) 6.2% PAT Margin 5 300 250 200 150 2000 1600 1200 Geographical and Segmental highlights Chemic

8.6%

17.5% 12.1 4.9 87.5 87.5 22.2 65.3 11.0% 0.8 66.1 11.1 572.5 6.9 579.4 529.4 50.0 8.6% 11.0 2.3 36.7 36.7 9.0 27.7 4.8% 0.3 28.0 4.7 2.8% 108.8% 890 bps 135.2% 620 bps 52

4.8%

.3 11.0% 0.8 66.1 11.1 572.5 6.9 579.4 529.4 50.0 8.6% 11.0 2.3 36.7 36.7 9.0 27.7 4.8% 0.3 28.0 4.7 2.8% 108.8% 890 bps 135.2% 620 bps 523.5 6.6 530.1 480.4 49.7 9.4% 11.7

2.8%

11.1 572.5 6.9 579.4 529.4 50.0 8.6% 11.0 2.3 36.7 36.7 9.0 27.7 4.8% 0.3 28.0 4.7 2.8% 108.8% 890 bps 135.2% 620 bps 523.5 6.6 530.1 480.4 49.7 9.4% 11.7 4.7 33.3 33.3 9.1

108.8%

572.5 6.9 579.4 529.4 50.0 8.6% 11.0 2.3 36.7 36.7 9.0 27.7 4.8% 0.3 28.0 4.7 2.8% 108.8% 890 bps 135.2% 620 bps 523.5 6.6 530.1 480.4 49.7 9.4% 11.7 4.7 33.3 33.3 9.1 24.2

890 bps

.9 579.4 529.4 50.0 8.6% 11.0 2.3 36.7 36.7 9.0 27.7 4.8% 0.3 28.0 4.7 2.8% 108.8% 890 bps 135.2% 620 bps 523.5 6.6 530.1 480.4 49.7 9.4% 11.7 4.7 33.3 33.3 9.1 24.2 4.6% -0.

135.2%

529.4 50.0 8.6% 11.0 2.3 36.7 36.7 9.0 27.7 4.8% 0.3 28.0 4.7 2.8% 108.8% 890 bps 135.2% 620 bps 523.5 6.6 530.1 480.4 49.7 9.4% 11.7 4.7 33.3 33.3 9.1 24.2 4.6% -0.2 24.0

Investor Relations Advisors

1

Investor Relations Advisors

IOL Chemicals & Pharmaceuticals Ltd. Adfactorspr Pvt. Ltd. Mr. Pardeep Kumar Khanna, CFO pardeepkhanna@iolcp.com Snighter Albuquerque snighter.a@adfactorspr.com www.iolcp.com Darshan Mankad darshan.mankad@adfactorspr.com www.adfactorspr.com